Moderna
Moderna is a biotechnology company known for its pioneering work in messenger RNA (mRNA) technology, particularly for its COVID-19 vaccine. Founded in 2010, it has rapidly gained prominence in the pharmaceutical industry, especially during the global pandemic. In recent financial reports, Moderna indicated a significant decline in revenue from its COVID-19 vaccine as demand decreases, leading to a reported loss of $1.12 billion for the fourth quarter. The company plans to diversify its portfolio by developing vaccines for other diseases, including influenza and cancer, and anticipates launching ten new products within the next three years.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
France:
Moderna is one of the three main stars in the anti-Covid-19 saga.
9
Bulgaria:
Moderna reported higher than expected revenues for the fourth quarter, but its losses exceeded forecasts due to declining demand for its COVID vaccine.
4